Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Cell & Gene Therapy

Stem cell research and commercialization in China...

Porton Biologics Raises $61 Million for Cell/Gene Therapy CDMO Services

BDgene Completes $9 Million Round for CRISPR/Cas9 mRNA Candidates

Gracell Reports Positive Data from Trial of Off-the Shelf CAR-T Candidate

Qihan Raises $67 Million for Gene Editing of Cell Therapies, Organ Transplant Drugs

WuXi AppTec Pays $135 Million to Acquire Oxgene, a Gene Therapy CDMO

Upcoming event
Shanghai and Digital
May 10-14, 2021
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
The Ritz-Carlton Shanghai Pudong
March 23-25, 2021